Analyst Consensus ?
ConsensusBuy61 ratings
Bullish4472.1%
Neutral1524.6%
Bearish23.3%
FN2 Earnings Intelligence
Halliburton Company analyst ratings
Halliburton Company (HAL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$33.5Current
$23Low
$37.67Average
$53High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 16, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Sep 14, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 23, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Freedom Broker | Hold | Sell | Upgrade | Jul 22, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Piper Sandler | Overweight | Neutral | Upgrade | Jul 14, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 8, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 3, 2026 |
| Stifel | Buy | Buy | Maintain | Apr 22, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 22, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Mar 25, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 22, 2026 |
| Freedom Capital Markets | Sell | Hold | Downgrade | Jan 6, 2026 |
| HSBC | Buy | Hold | Upgrade | Oct 22, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 23, 2025 |
| Benchmark | Buy | Buy | Maintain | Jan 23, 2025 |
| Jefferies | Buy | Buy | Maintain | Jan 3, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Nov 8, 2024 |
| B of A Securities | Buy | Buy | Maintain | Oct 14, 2024 |
| Wolfe Research | Outperform | Underperform | Upgrade | Jan 12, 2023 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Apr 20, 2022 |
| BNP Paribas | Neutral | Underperform | Upgrade | Jul 21, 2021 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 22, 2021 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Jan 25, 2021 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Jul 15, 2020 |
| Northland Capital Markets | Perform | Market Perform | Maintain | May 29, 2020 |
| Bernstein | Perform | Market Perform | Maintain | Jan 14, 2020 |
| ScotiaBank | Sector Outperform | Sector Perform | Upgrade | Jan 6, 2020 |
| Deutsche Bank | Buy | Buy | Maintain | Nov 20, 2019 |
| Bank of America | Buy | Buy | Maintain | Sep 5, 2019 |
| Societe Generale | Buy | Hold | Upgrade | Dec 20, 2018 |
| Cleveland Research | Neutral | Buy | Downgrade | Oct 18, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 11, 2018 |
| Argus | Hold | Hold | Maintain | May 5, 2018 |
| Guggenheim | Buy | Neutral | Upgrade | Jan 22, 2018 |
| Loop Capital | Buy | Buy | Maintain | Oct 24, 2017 |
| Seaport Global | Neutral | Buy | Downgrade | Jun 21, 2017 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jan 18, 2017 |
| Nomura | Buy | Buy | Maintain | Oct 20, 2016 |
| iBERIA Capital Partners | Outperform | Outperform | Maintain | Oct 20, 2016 |
| DA Davidson | Buy | Buy | Maintain | Oct 19, 2016 |
| FBR Capital | Outperform | Outperform | Maintain | Jul 21, 2016 |
| Griffin Securities | Buy | Buy | Maintain | May 19, 2016 |
| KLR Group | Buy | Accumulate | Maintain | Jan 28, 2016 |
| Baird | Neutral | Neutral | Maintain | Jan 26, 2016 |
| KeyBanc | Overweight | Sector Weight | Upgrade | Jan 5, 2016 |
| GMP Securities | Buy | Buy | Maintain | Jan 5, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Oct 20, 2015 |
| Oppenheimer | Outperform | Outperform | Maintain | Oct 1, 2015 |
| CLSA | Underperform | Outperform | Downgrade | Apr 20, 2015 |
| ISI Group | Buy | Buy | Maintain | Oct 16, 2014 |
| Drexel Hamilton | Buy | Buy | Maintain | Jun 20, 2014 |
| Global Hunter Securities | Neutral | Buy | Downgrade | Nov 18, 2013 |
| MLV & Co. | Buy | Hold | Upgrade | Jan 28, 2013 |
| Dahlman Rose | Buy | Buy | Maintain | Jan 28, 2013 |
| Standpoint Research | Hold | Buy | Downgrade | Jan 8, 2013 |
| Pritchard Capital Partners | Buy | Buy | Maintain | Apr 19, 2012 |
| Bank oferica | Buy | Buy | Maintain | Apr 19, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $33.5. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $42 | $35.84 | +25.4% | Sep 14, 2026 |
| UBS | Josh Silverstein | $39 | $32.7 | +16.4% | Jul 27, 2026 |
| Argus Research | Bill Selesky | $40 | $33.68 | +19.4% | Jul 23, 2026 |
| BMO Capital | Analyst unavailable | $37 | $33.22 | +10.4% | Jul 22, 2026 |
| Evercore ISI | Stephen Richardson | $43 | $33.52 | +28.4% | Jul 22, 2026 |
| Barclays | Analyst unavailable | $53 | $33.19 | +58.2% | Jul 22, 2026 |
| Morgan Stanley | Analyst unavailable | $41 | $35.52 | +22.4% | Jul 15, 2026 |
| Piper Sandler | Analyst unavailable | $43 | $35.21 | +28.4% | Jul 14, 2026 |
| Susquehanna | Analyst unavailable | $42 | $33.79 | +25.4% | Jul 8, 2026 |
| UBS | Analyst unavailable | $40 | $33.24 | +19.4% | Jul 2, 2026 |
| Barclays | Analyst unavailable | $55 | $40.4 | +64.2% | May 7, 2026 |
| Jefferies | Analyst unavailable | $47 | $40.36 | +40.3% | Apr 26, 2026 |
| Morgan Stanley | Analyst unavailable | $40 | $37.51 | +19.4% | Apr 15, 2026 |
| Barclays | Analyst unavailable | $29 | $37.69 | -13.4% | Apr 9, 2026 |
| Jefferies | Analyst unavailable | $39 | $33.84 | +16.4% | Feb 6, 2026 |
| UBS | Analyst unavailable | $35 | $34.56 | +4.5% | Jan 23, 2026 |
| BMO Capital | Analyst unavailable | $39 | $33.72 | +16.4% | Jan 23, 2026 |
| RBC Capital | Keith Mackey | $38 | $33.08 | +13.4% | Jan 22, 2026 |
| Evercore ISI | Jason Bandel | $36 | $32.94 | +7.5% | Jan 22, 2026 |
| Stifel Nicolaus | Analyst unavailable | $36 | $33.55 | +7.5% | Jan 22, 2026 |
| Goldman Sachs | Neil Mehta | $40 | $33.55 | +19.4% | Jan 22, 2026 |
| Susquehanna | Charles Minervino | $40 | $33.36 | +19.4% | Jan 22, 2026 |
| Morgan Stanley | Analyst unavailable | $35 | $33.25 | +4.5% | Jan 21, 2026 |
| Stifel Nicolaus | Analyst unavailable | $35 | $33.38 | +4.5% | Jan 21, 2026 |
| RBC Capital | Keith Mackey | $36 | $32.8 | +7.5% | Jan 15, 2026 |
| Goldman Sachs | Analyst unavailable | $35 | $32.61 | +4.5% | Jan 14, 2026 |
| Piper Sandler | Derek Podhaizer | $30 | $32.61 | -10.4% | Jan 14, 2026 |
| Susquehanna | Analyst unavailable | $36 | $30.62 | +7.5% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $35 | $31.92 | +4.5% | Jan 6, 2026 |
| Piper Sandler | Analyst unavailable | $29 | $27.74 | -13.4% | Dec 18, 2025 |
| Morgan Stanley | Analyst unavailable | $34 | $28.32 | +1.5% | Dec 15, 2025 |
| UBS | Analyst unavailable | $32 | $28.74 | -4.5% | Dec 12, 2025 |
| Redburn Partners | Sebastian Erskine | $35 | $26.84 | +4.5% | Nov 3, 2025 |
| Goldman Sachs | Analyst unavailable | $28 | $26.31 | -16.4% | Oct 23, 2025 |
| Barclays | David Anderson | $25 | $27.04 | -25.4% | Oct 23, 2025 |
| UBS | Analyst unavailable | $24 | $26.14 | -28.4% | Oct 22, 2025 |
| Piper Sandler | Derek Podhaizer | $27 | $25.24 | -19.4% | Oct 22, 2025 |
| Susquehanna | Analyst unavailable | $29 | $25.24 | -13.4% | Oct 22, 2025 |
| Stifel Nicolaus | Stephen Gengaro | $32 | $25.24 | -4.5% | Oct 22, 2025 |
| HSBC | Analyst unavailable | $30 | $25.24 | -10.4% | Oct 22, 2025 |
| RBC Capital | Keith Mackey | $31 | $25.24 | -7.5% | Oct 22, 2025 |
| Barclays | Analyst unavailable | $20 | $22.5 | -40.3% | Oct 14, 2025 |
| UBS | Analyst unavailable | $23 | $24.31 | -31.3% | Oct 6, 2025 |
| Wells Fargo | Roger Read | $27 | $20.61 | -19.4% | Apr 23, 2025 |
| Griffin | Kevin Simpson | $28 | $26.08 | -16.4% | Dec 20, 2024 |
| Wells Fargo | Roger Read | $39 | $29.97 | +16.4% | Sep 24, 2024 |
| Jefferies | Lloyd Byrne | $46 | $29.97 | +37.3% | Sep 24, 2024 |
| RBC Capital | Sector Perform | $37 | $28.02 | +10.4% | Sep 13, 2024 |
| Barclays | David Anderson | $48 | $33.39 | +43.3% | Jul 23, 2024 |
| Stifel Nicolaus | Stephen Gengaro | $45 | $33.39 | +34.3% | Jul 22, 2024 |
| Susquehanna | Charles Minervino | $46 | $34.02 | +37.3% | Jul 22, 2024 |
| Evercore ISI | James West | $48 | $33.99 | +43.3% | Jul 22, 2024 |
| Piper Sandler | Luke Lemoine | $40 | $34.4 | +19.4% | Jul 22, 2024 |
| RBC Capital | Keith Mackey | $44 | $34.4 | +31.3% | Jul 22, 2024 |
| Evercore ISI | James West | $52 | $34.4 | +55.2% | Jul 19, 2024 |
| Wolfe Research | Sam Margolin | $52 | $38.79 | +55.2% | Apr 23, 2024 |
| Raymond James | Praveen Narra | $49 | $37.01 | +46.3% | Jul 20, 2023 |
| Wells Fargo | Christopher Voie | $33 | $29.3 | -1.5% | Jul 30, 2022 |
| Barclays | David Anderson | $50 | $35.62 | +49.3% | Apr 29, 2022 |
| HSBC | Abhishek Kumar | $41.6 | $35.94 | +24.2% | Apr 28, 2022 |
| RBC Capital | Keith Mackey | $49 | $35.16 | +46.3% | Apr 25, 2022 |
| Susquehanna | Charles Minervino | $48 | $39.6 | +43.3% | Apr 20, 2022 |
| Citigroup | Analyst unavailable | $48 | $39.89 | +43.3% | Apr 20, 2022 |
| Stephens | Analyst unavailable | $40 | $39.47 | +19.4% | Apr 20, 2022 |
| Stifel Nicolaus | Stephen Gengaro | $42 | $39.06 | +25.4% | Apr 11, 2022 |
| Morgan Stanley | Connor Lynagh | $45 | $39.06 | +34.3% | Apr 11, 2022 |
| BMO Capital | Phillip Jungwirth | $32 | $30.48 | -4.5% | Jan 25, 2022 |
| RBC Capital | Keith Mackey | $34 | $30.59 | +1.5% | Jan 25, 2022 |
| Cowen & Co. | Marc Bianchi | $35 | $30.48 | +4.5% | Jan 25, 2022 |
| Stephens | Tommy Moll | $38 | $30.48 | +13.4% | Jan 25, 2022 |
| Griffin | Kevin Simpson | $32 | $23.9 | -4.5% | Jan 3, 2022 |
| Benchmark Co. | Douglas Becker | $31 | $21.92 | -7.5% | Nov 19, 2021 |
| Barclays | David Anderson | $36 | $26.31 | +7.5% | Oct 20, 2021 |
| Argus Research | Bill Selesky | $32 | $26.31 | -4.5% | Oct 20, 2021 |
| Coker Palmer | Vaibhav Vaishnav | $24 | $24.36 | -28.4% | Oct 12, 2021 |
| HSBC | Abhishek Kumar | $18.2 | $19.33 | -45.7% | Aug 5, 2021 |
| Piper Sandler | Ian Macpherson | $25.5 | $20.61 | -23.9% | Jul 21, 2021 |
| Goldman Sachs | Neil Mehta | $26 | $20.61 | -22.4% | Jul 21, 2021 |
| BNP Paribas | Nick Konstantakis | $23 | $20.61 | -31.3% | Jul 21, 2021 |
Track every rating change on HAL the moment it posts. Free to start.
Start freeGet the HAL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.